Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prostate Cancer, Castration Resistant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT04087174
What this trial is testing

A Multi-centre Study to Assess the Safety, Tolerability, and Pharmacokinetics of Capivasertib (AZD5363) in Combination With Novel Agents in Patients With Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
AstraZeneca 27
Testing effectiveness (Phase 2)Active Not RecruitingNCT07047118
What this trial is testing

JSB462 (Luxdegalutamide) Plus Lutetium (177Lu) Vipivotide Tetraxetan in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)

Who this might be right for
Prostatic Cancer, Castration-Resistant
Novartis Pharmaceuticals 138
Testing effectiveness (Phase 2)UnknownNCT03506997
What this trial is testing

Trial of Pembrolizumab in Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Castration-resistant Prostate Cancer
Institute of Cancer Research, United Kingdom 100
Early research (Phase 1)Looking for participantsNCT07103018
What this trial is testing

A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)

Who this might be right for
Metastatic Castration-resistant Prostate CancerMetastatic Castration-Resistant Prostate Cancer PatientsMetastatic Castration-resistant Prostate Cancer, mCRPC+2 more
K36 Therapeutics, Inc. 144
Not applicableLooking for participantsNCT06334120
What this trial is testing

An Observational Study to Learn More About the Safety of Darolutamide in Men With Prostate Cancer in Korea

Who this might be right for
Non-metastatic Castration-resistant Prostate CancerMetastatic Hormone-sensitive Prostate Cancer
Bayer 600
Testing effectiveness (Phase 2)Looking for participantsNCT06059118
What this trial is testing

Difluoromethylornithine and High Dose Testosterone With Enzalutamide in Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 50
Early research (Phase 1)Study completedNCT04179396
What this trial is testing

Study of Oral Rucaparib With Other Anticancer Agents in Metastatic Castration Resistant Prostate Cancer Patients (RAMP)

Who this might be right for
Metastatic Castration Resistant Prostate Cancer
pharmaand GmbH 8
Testing effectiveness (Phase 2)Active Not RecruitingNCT06383052
What this trial is testing

177Lu-NYM032 Injection in mCRPC

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Norroy Bioscience Co., LTD 30
Testing effectiveness (Phase 2)UnknownNCT04148885
What this trial is testing

A Trial of Paclitaxel (Albumin-binding) for Castration-resistant Prostate Cancer

Who this might be right for
Castration-resistant Prostate Cancer
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 44
Testing effectiveness (Phase 2)Study completedNCT04288687
What this trial is testing

A Trial of Niraparib in Platinum-Sensitive Castration-Resistant Prostate Cancer With DNA Repair Defects

Who this might be right for
Prostate Adenocarcinoma
Abramson Cancer Center at Penn Medicine 11
Testing effectiveness (Phase 2)Study completedNCT01074138
What this trial is testing

Safety and Efficacy Study of KX2-391 for Treatment of Bone-Metastatic, Castration-Resistant Prostate Cancer

Who this might be right for
Bone-Metastatic, Castration-Resistant Prostate Cancer
Athenex, Inc. 31
Early research (Phase 1)Active Not RecruitingNCT05245006
What this trial is testing

PET Imaging Study of 89Zr-DFO-YS5 in Men With Prostate Cancer

Who this might be right for
Prostate CancerMetastatic Castration-resistant Prostate Cancer
Robert Flavell, MD, PhD 30
Not applicableLooking for participantsNCT07050433
What this trial is testing

COMPASS Study for Metastatic Castration-resistant Prostate Cancer

Who this might be right for
Prostate Cancer
Duke University 48
Testing effectiveness (Phase 2)WithdrawnNCT02966587
What this trial is testing

Durvalumab in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer

Who this might be right for
Castration Levels of TestosteroneHormone-Resistant Prostate CancerMicrosatellite Instability
University of Washington
Testing effectiveness (Phase 2)Ended earlyNCT05489991
What this trial is testing

TmPSMA-02 Chimeric Antigen Receptor (CAR) T-cells in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Tceleron Therapeutics, Inc. 1
Testing effectiveness (Phase 2)Looking for participantsNCT06610825
What this trial is testing

Castrate Resistant Prostate Cancer Enhertu Therapy

Who this might be right for
Prostate Cancer MetastaticProstate CancerCRPC
Washington D.C. Veterans Affairs Medical Center 60
Testing effectiveness (Phase 2)Looking for participantsNCT05563558
What this trial is testing

Pembrolizumab, Carboplatin and Cabazitaxel in Aggressive Metastatic Castration Resistant Prostate Cancer (PEAPOD_FOS)

Who this might be right for
Prostate Cancer Metastatic
Fundacion Oncosur 42
Testing effectiveness (Phase 2)Looking for participantsNCT04868604
What this trial is testing

64Cu-SAR-bisPSMA and 67Cu-SAR-bisPSMA for Identification and Treatment of PSMA-expressing Metastatic Castrate Resistant Prostate Cancer (SECuRE)

Who this might be right for
Prostatic Neoplasms, Castration-Resistant
Clarity Pharmaceuticals Ltd 54
Early research (Phase 1)Study completedNCT03778047
What this trial is testing

A Study Evaluating Enzalutamide Pharmacokinetics and Pharmacodynamics, and Related Changes After Drug Switch

Who this might be right for
Metastatic Castration Resistant Prostate Cancer
Hinova Pharmaceuticals Inc. 10
Large-scale testing (Phase 3)Not Yet RecruitingNCT07641855
What this trial is testing

BL-B01D1 Combination Therapy in Patients With Metastatic Castration-resistant Prostate Cancer

Who this might be right for
Castration-resistant Prostate Cancer
Sichuan Baili Pharmaceutical Co., Ltd. 180
Next Page